サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
表紙：ヒトミルクオリゴ糖の世界市場：規模、シェア、動向分析、機会、予測（2019年～2029年）：タイプ別、流通チャネル別、用途別、地域別
市場調査レポート
商品コード
1267378

ヒトミルクオリゴ糖の世界市場：規模、シェア、動向分析、機会、予測（2019年～2029年）：タイプ別、流通チャネル別、用途別、地域別

Human Milk Oligosaccharides Market - Size, Share, Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Type ; By Distribution Channel ; By Application ; By Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 400 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ヒトミルクオリゴ糖の世界市場：規模、シェア、動向分析、機会、予測（2019年～2029年）：タイプ別、流通チャネル別、用途別、地域別
出版日: 2023年04月25日
発行: Blueweave Consulting
ページ情報: 英文 400 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のヒトミルクオリゴ糖の市場規模は、2022年に1億9,900万米ドルとなりました。今後、2023年～2029年にかけて22.9%の強固なCAGRで拡大し、2029年には8億4,278万米ドルに達すると予測されています。

当レポートでは、世界のヒトミルクオリゴ糖市場について調査し、市場の概要とともに、タイプ別、流通チャネル別、用途別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界のヒトミルクオリゴ糖（HMO）市場の洞察

  • 業界バリューチェーン分析
  • DROC分析
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 製品の進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析

第4章 世界のヒトミルクオリゴ糖（HMO）市場の概要

  • 市場規模と予測、2019年～2029年
  • 市場シェアと予測
    • タイプ別
      • 2'FL
      • 3'FL
      • 3'SL
      • 6'SL
    • 流通チャネル別
      • ハイパーマーケットとスーパーマーケット
      • ドラッグストアまたは薬局
      • 量販店
      • デパート
      • モノブランド店
      • 専門店
      • オンライン販売チャネル
      • その他
    • 用途別
      • 乳児用調製粉乳
      • 機能性食品・飲料
      • 栄養補助食品
      • 健康成分
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • ラテンアメリカ
      • 中東・アフリカ

第5章 北米のヒトミルクオリゴ糖（HMO）市場

第6章 欧州のヒトミルクオリゴ糖（HMO）市場

第7章 アジア太平洋のヒトミルクオリゴ糖（HMO）市場

第8章 ラテンアメリカのヒトミルクオリゴ糖（HMO）市場

第9章 中東・アフリカのヒトミルクオリゴ糖（HMO）市場

第10章 競合情勢

第11章 COVID-19が世界のヒトミルクオリゴ糖（HMO）市場に与える影響

第12章 企業プロファイル

  • Abbott Laboratories
  • FrieslandCampina Domo
  • DuPont Nutrition & Health
  • Jennewein Biotechnologie GmbH
  • Glycom A/S
  • Nestle S.A.
  • Inbiose NV
  • ZuChem Inc.
  • InnoBio Ltd.
  • Elicityl SA
  • TCI Chemicals（India）Pvt. Ltd.
  • Medolac Laboratories
  • Glycosyn LLC
  • Glycosyn-Stanford JV LLC
  • ProZomix Limited
  • その他

第13章 主要な戦略的推奨事項

第14章 調査手法

目次
Product Code: BWC23330

Global Human Milk Oligosaccharides (HMO) Market Size Booming More Than 4X at Robust CAGR of 23% During 2023-2029.

Global Human Milk Oligosaccharides (HMO) market is gaining traction because of the growing awareness about the benefits of HMOs in infant nutrition, including supporting digestive health and technology advancements, such as microbial fermentation, enzymatic synthesis, and chemical synthesis, in HMO production.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global Human Milk Oligosaccharides (HMO) market size at USD 199 million in 2022. During the forecast period between 2023 and 2029, the global Human Milk Oligosaccharides (HMO) market size is projected to grow at a robust CAGR of 22.9% reaching a value of USD 842.78 million by 2029. The development of R&D efforts and the increasing usage of HMO as a component in infant formula are two major growth factors for the global market for HMO. One of the primary factors propelling the growth of the human milk oligosaccharides (HMO) market is the accessibility of cutting-edge technologies like enzymatic trans-glycosylation, which is used to artificially synthesis the HMOs.

Global Human Milk Oligosaccharides (HMO) Market - Overview:

Human milk oligosaccharides (HMOs) are a group of complex carbohydrates and the third most prevalent solid substance in human milk after lipids and lactose. Mother's milk contains HMOs that are essential for the immune system and intestinal barrier development in a newborn. Some HMOs may also have an impact on how the infant's brain develops. Although there are more than 100 distinct kinds of HMOs, most moms' breast milk contains the most 2'-FL HMO (2'-fucosyllactose), which is the most common form.

Global Human Milk Oligosaccharides (HMO) Market - By Application:

Based on application, the global Human Milk Oligosaccharides (HMO) market is segmented into infant formula, functional food & beverages, food supplements, health ingredients, and others. The infant formula segment accounts for the highest market share. These HMO supplements shield newborns against infection. Additionally, it helps gut health maintenance, protects them from prebiotic effects, and boosts cognition. Therefore, most infant formula-making food companies add this component into their products, due to which its demand is gaining traction in the market.

Impact of COVID-19 on Global Human Milk Oligosaccharides (HMO) Market

The market for Human Milk Oligosaccharides (HMO) was significantly impacted by the COVID-19 pandemic. Due to panic buying for at-home consumption during the early stages of the pandemic, the demand for HMOs soared during the lockdown. Because HMOs operate as an immunity booster, their sales increased during the pandemic as a result. However, restrictions on production activities and a shortage of labor also created a huge demand and supply gap that impacted the market revenue negatively in the later period of the COVID-19 outbreak. But it is estimated that the market will overall gain new opportunities owing to the rising health consciousness among consumers.

Competitive Landscape:

Major players operating in the global Human Milk Oligosaccharides (HMO) market include: Abbott Laboratories, FrieslandCampina Domo, DuPont Nutrition & Health, Jennewein Biotechnologie GmbH, Glycom A/S, Nestle S.A., Inbiose NV, ZuChem Inc., InnoBio Ltd., Elicityl SA, TCI Chemicals (India) Pvt. Ltd., Medolac Laboratories, Glycosyn LLC, Glycosyn-Stanford JV LLC, and ProZomix Limited.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Human Milk Oligosaccharides (HMO) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Human Milk Oligosaccharides (HMO) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Human Milk Oligosaccharides (HMO) Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Growing awareness about the benefits of HMOs in infant nutrition, including supporting digestive health
      • 3.2.1.2. Technological advancements in HMO production, such as microbial fermentation, enzymatic synthesis, and chemical synthesis
      • 3.2.1.3. Rising prevalence of infant health issues, such as diarrhea, constipation, and allergies
    • 3.2.2. Restraints
      • 3.2.2.1. Stringent regulatory frameworks and labeling requirements for Human Milk Oligosaccharides (HMO)
      • 3.2.2.2. Limited availability of HMOs from natural sources, as they are only found in human milk and can be difficult to extract and purify
    • 3.2.3. Opportunities
      • 3.2.3.1. Rising demand for natural and sustainable ingredients in food and beverage products
      • 3.2.3.2. Expansion of the global infant formula market, particularly in emerging markets
    • 3.2.4. Challenges
      • 3.2.4.1. Increasing competition from alternative sources of functional ingredients, such as probiotics, prebiotics, and vitamins
  • 3.3. Product Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Human Milk Oligosaccharides (HMO) Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Type
      • 4.2.1.1. 2'FL
      • 4.2.1.2. 3'FL
      • 4.2.1.3. 3'SL
      • 4.2.1.4. 6'SL
    • 4.2.2. By Distribution Channel
      • 4.2.2.1. Hypermarkets & Supermarkets
      • 4.2.2.2. Drug Store or Pharmacy
      • 4.2.2.3. Mass Merchandiser
      • 4.2.2.4. Departmental Stores
      • 4.2.2.5. Mono-brand Stores
      • 4.2.2.6. Specialty Stores
      • 4.2.2.7. Online Sales Channel
      • 4.2.2.8. Others
    • 4.2.3. By Application
      • 4.2.3.1. Infant Formula
      • 4.2.3.2. Functional Food & Beverages
      • 4.2.3.3. Food Supplements
      • 4.2.3.4. Health Ingredients
      • 4.2.3.5. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Human Milk Oligosaccharides (HMO) Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Distribution Channel
    • 5.2.3. By Application
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Type
      • 5.2.4.1.2. By Distribution Channel
      • 5.2.4.1.3. By Application
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Type
      • 5.2.4.2.2. By Distribution Channel
      • 5.2.4.2.3. By Application

6. Europe Human Milk Oligosaccharides (HMO) Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Application
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Type
      • 6.2.4.1.2. By Distribution Channel
      • 6.2.4.1.3. By Application
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Type
      • 6.2.4.2.2. By Distribution Channel
      • 6.2.4.2.3. By Application
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Type
      • 6.2.4.3.2. By Distribution Channel
      • 6.2.4.3.3. By Application
      • 6.2.4.4. France
      • 6.2.4.4.1. By Type
      • 6.2.4.4.2. By Distribution Channel
      • 6.2.4.4.3. By Application
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Type
      • 6.2.4.5.2. By Distribution Channel
      • 6.2.4.5.3. By Application
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Type
      • 6.2.4.6.2. By Distribution Channel
      • 6.2.4.6.3. By Application
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Type
      • 6.2.4.7.2. By Distribution Channel
      • 6.2.4.7.3. By Application
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Type
      • 6.2.4.8.2. By Distribution Channel
      • 6.2.4.8.3. By Application
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Type
      • 6.2.4.9.2. By Distribution Channel
      • 6.2.4.9.3. By Application

7. Asia Pacific Human Milk Oligosaccharides (HMO) Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Application
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Type
      • 7.2.4.1.2. By Distribution Channel
      • 7.2.4.1.3. By Application
      • 7.2.4.2. India
      • 7.2.4.2.1. By Type
      • 7.2.4.2.2. By Distribution Channel
      • 7.2.4.2.3. By Application
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Type
      • 7.2.4.3.2. By Distribution Channel
      • 7.2.4.3.3. By Application
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Type
      • 7.2.4.4.2. By Distribution Channel
      • 7.2.4.4.3. By Application
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Type
      • 7.2.4.5.2. By Distribution Channel
      • 7.2.4.5.3. By Application
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Type
      • 7.2.4.6.2. By Distribution Channel
      • 7.2.4.6.3. By Application
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Type
      • 7.2.4.7.2. By Distribution Channel
      • 7.2.4.7.3. By Application
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Type
      • 7.2.4.8.2. By Distribution Channel
      • 7.2.4.8.3. By Application
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Type
      • 7.2.4.9.2. By Distribution Channel
      • 7.2.4.9.3. By Application
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Type
      • 7.2.4.10.2. By Distribution Channel
      • 7.2.4.10.3. By Application

8. Latin America Human Milk Oligosaccharides (HMO) Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Type
      • 8.2.4.1.2. By Distribution Channel
      • 8.2.4.1.3. By Application
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Type
      • 8.2.4.2.2. By Distribution Channel
      • 8.2.4.2.3. By Application
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Type
      • 8.2.4.3.2. By Distribution Channel
      • 8.2.4.3.3. By Application
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Type
      • 8.2.4.4.2. By Distribution Channel
      • 8.2.4.4.3. By Application
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Type
      • 8.2.4.5.2. By Distribution Channel
      • 8.2.4.5.3. By Application

9. Middle East & Africa Human Milk Oligosaccharides (HMO) Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Application
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Type
      • 9.2.4.1.2. By Distribution Channel
      • 9.2.4.1.3. By Application
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Type
      • 9.2.4.2.2. By Distribution Channel
      • 9.2.4.2.3. By Application
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Type
      • 9.2.4.3.2. By Distribution Channel
      • 9.2.4.3.3. By Application
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Type
      • 9.2.4.4.2. By Distribution Channel
      • 9.2.4.4.3. By Application
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Type
      • 9.2.4.5.2. By Distribution Channel
      • 9.2.4.5.3. By Application
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Type
      • 9.2.4.6.2. By Distribution Channel
      • 9.2.4.6.3. By Application
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Type
      • 9.2.4.7.2. By Distribution Channel
      • 9.2.4.7.3. By Application
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Type
      • 9.2.4.8.2. By Distribution Channel
      • 9.2.4.8.3. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Human Milk Oligosaccharides (HMO) Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Human Milk Oligosaccharides (HMO) Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Abbott Laboratories
  • 12.2. FrieslandCampina Domo
  • 12.3. DuPont Nutrition & Health
  • 12.4. Jennewein Biotechnologie GmbH
  • 12.5. Glycom A/S
  • 12.6. Nestle S.A.
  • 12.7. Inbiose NV
  • 12.8. ZuChem Inc.
  • 12.9. InnoBio Ltd.
  • 12.10. Elicityl SA
  • 12.11. TCI Chemicals (India) Pvt. Ltd.
  • 12.12. Medolac Laboratories
  • 12.13. Glycosyn LLC
  • 12.14. Glycosyn-Stanford JV LLC
  • 12.15. ProZomix Limited
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations